Related Experiment Video

Updated: Nov 10, 2025

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

10.1K

Small GTPases in Cancer: Still Signaling the Way

Paulo Matos1,2

  • 1BioISI-Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, 1749-016 Lisbon, Portugal.

Cancers
|April 3, 2021
PubMed

Insights

Recent decades have seen significant progress in early cancer diagnosis and treatment. Continued research is crucial for further improving patient outcomes and survival rates.

Area of Science:

  • Oncology
  • Medical Diagnostics
  • Cancer Therapeutics

Background:

  • Significant advancements in early cancer detection methods have been achieved.
  • Innovative treatment strategies have been developed, improving patient prognosis.
  • The field of oncology has witnessed transformative progress in recent decades.

Discussion:

  • The integration of novel diagnostic tools enhances the accuracy and timeliness of cancer identification.
  • Therapeutic breakthroughs are leading to more personalized and effective cancer treatment regimens.
  • Multidisciplinary approaches are essential for optimizing cancer care pathways.

Key Insights:

  • Early diagnosis remains a critical factor in successful cancer treatment and patient survival.
  • The development of targeted therapies and immunotherapies represents a major leap in cancer treatment.
  • Ongoing research continuously refines our understanding of cancer biology, paving the way for future innovations.

Outlook:

  • Future research will likely focus on even earlier detection through biomarkers and advanced imaging.
  • Personalized medicine approaches will become more prevalent, tailoring treatments to individual genetic profiles.
  • Continued innovation in cancer therapeutics promises improved efficacy and reduced side effects.

More Related Videos

RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

12.7K
Comparing the Affinity of GTPase-binding Proteins using Competition Assays10:37

Comparing the Affinity of GTPase-binding Proteins using Competition Assays

Published on: October 8, 2015

9.4K

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.6K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.3K
GTPases and their Regulation02:14

GTPases and their Regulation

2.6K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.7K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
8.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K